Foundry Partners LLC Has $445,000 Stock Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Foundry Partners LLC lowered its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 17.8% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 6,137 shares of the company’s stock after selling 1,330 shares during the quarter. Foundry Partners LLC’s holdings in Prestige Consumer Healthcare were worth $445,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of PBH. Congress Asset Management Co. MA boosted its position in Prestige Consumer Healthcare by 596.2% during the 4th quarter. Congress Asset Management Co. MA now owns 679,256 shares of the company’s stock worth $41,584,000 after acquiring an additional 581,685 shares during the last quarter. Norges Bank acquired a new stake in shares of Prestige Consumer Healthcare in the 4th quarter valued at approximately $27,739,000. Norden Group LLC boosted its holdings in shares of Prestige Consumer Healthcare by 1,593.7% in the 1st quarter. Norden Group LLC now owns 118,968 shares of the company’s stock valued at $8,632,000 after buying an additional 111,944 shares during the last quarter. UBS Group AG boosted its holdings in shares of Prestige Consumer Healthcare by 377.6% in the 4th quarter. UBS Group AG now owns 131,382 shares of the company’s stock valued at $8,043,000 after buying an additional 103,872 shares during the last quarter. Finally, Congress Wealth Management LLC DE boosted its holdings in shares of Prestige Consumer Healthcare by 246.1% in the 4th quarter. Congress Wealth Management LLC DE now owns 114,220 shares of the company’s stock valued at $6,993,000 after buying an additional 81,215 shares during the last quarter. Institutional investors and hedge funds own 99.95% of the company’s stock.

Prestige Consumer Healthcare Stock Performance

PBH traded down $0.43 during trading hours on Friday, reaching $71.14. The company’s stock had a trading volume of 30,776 shares, compared to its average volume of 245,485. Prestige Consumer Healthcare Inc. has a 52 week low of $56.34 and a 52 week high of $75.31. The company’s 50-day moving average is $66.86 and its 200-day moving average is $67.42. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.02 and a current ratio of 3.20. The firm has a market cap of $3.53 billion, a PE ratio of 17.16, a price-to-earnings-growth ratio of 2.03 and a beta of 0.49.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings data on Tuesday, May 14th. The company reported $1.02 earnings per share for the quarter, missing the consensus estimate of $1.14 by ($0.12). The firm had revenue of $277.00 million for the quarter, compared to the consensus estimate of $287.42 million. Prestige Consumer Healthcare had a return on equity of 13.48% and a net margin of 18.60%. The firm’s quarterly revenue was down 3.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.07 EPS. On average, equities analysts forecast that Prestige Consumer Healthcare Inc. will post 4.42 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms have recently commented on PBH. Canaccord Genuity Group reissued a “buy” rating and issued a $80.00 price objective on shares of Prestige Consumer Healthcare in a report on Tuesday, May 21st. DA Davidson raised Prestige Consumer Healthcare from a “neutral” rating to a “buy” rating and increased their price objective for the company from $65.00 to $93.00 in a report on Friday, June 21st. Finally, StockNews.com downgraded Prestige Consumer Healthcare from a “strong-buy” rating to a “buy” rating in a report on Tuesday, May 21st. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $98.25.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.